Atlas Trials

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

Clinical trial NCT01347645 · TERMINATED

Trial details

NCT number
NCT01347645
Sponsor
Eisai Inc.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Colon CancerRectal Cancer
Start date
2011-09-30
Primary completion
2015-06-22
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.